Manufacturer
Meridian Medical Technologies
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 7
- Molecules
- 3
- Therapy areas
- 2
Meridian Medical Technologies is a pharmaceutical manufacturer based in United States. MedsAcross lists 7 of its products across 3 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Meridian Medical Technologies LLC, Meridian Medical Technologies, LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Meridian Medical Technologies products through licensed channels, with the documents your regulator needs.
Ophthalmology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| ATROPEN Auto-Injector 0.25 mg/0.3 mL injectionIntramuscular | Atropine | US FDA | Available on request |
| ATROPEN Auto-Injector 0.5 mg/0.7 mL injectionIntramuscular | Atropine | US FDA | Available on request |
| ATROPEN Auto-Injector 1 mg/0.7 mL injectionIntramuscular | Atropine | US FDA | Available on request |
| ATROPEN Auto-Injector 2 mg/0.7 mL injectionIntramuscular | Atropine | US FDA | Available on request |
Psychiatry
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Diazepam 10 mg/2 mL injectionIntramuscularGeneric name | Diazepam | US FDA | Available on request |
Other products
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| ATNAA atropine and pralidoxime chloride Auto-Injector kitIntramuscular | Atropine and Pralidoxime | US FDA | Available on request |
| DuoDote kitIntramuscular | Atropine and Pralidoxime | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Meridian Medical Technologies
Send a request for any of these products. We confirm the licensed source, documents and lead time.